C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2571154
A serum assay for JM-27 identifies individuals having benign prostate hyperplasia (BPH). by means of the serum assay, methods of diagnosing BPH, methods of determining the severity of , methods of monitoring the course of therapy and methods of monitoring the progression of are performed.
Selon l'invention, une épreuve sérologique pour JM-27 identifie des individus atteints d'une hypertrophie bénigne de la prostate (HBP). Cette épreuve sérologique permet de mettre en oeuvre des procédés de diagnostic d'une HBP, des procédés pour déterminer la gravité d'une HBP, des procédés de contrôle de l'évolution du traitement d'une HBP et des procédés de contrôle de la progression d'une HBP.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
University Of Pittsburgh
LandOfFree
Jm-27 asa a marker of benign prostatic hyperplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Jm-27 asa a marker of benign prostatic hyperplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Jm-27 asa a marker of benign prostatic hyperplasia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846987